Ipswich Investment Management’s Biogen BIIB Stock Holding History

Ipswich Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-780	Closed	-$247K	–	167
2020 Q1	$247K	Sell	780 -25	-3%	-$7.59K	0.1%	138
2019 Q4	$239K	Sell	805 -215	-21%	-$59.7K	0.07%	166
2019 Q3	$237K	Sell	1,020 -3,680	-78%	-$857K	0.08%	164
2019 Q2	$1.1M	Sell	4,700 -2,209	-32%	-$510K	0.35%	70
2019 Q1	$1.63M	Buy	6,909 +570	+9%	+$179K	0.53%	57
2018 Q4	$1.91M	Sell	6,339 -6	-0.1%	-$1.92K	0.7%	41
2018 Q3	$2.24M	Buy	+6,345	New	+$2.18M	0.76%	45
2018 Q2	–	Sell	-5,951	Closed	-$1.63M	–	91
2018 Q1	$1.63M	Buy	5,951 +15	+0.3%	+$4.66K	0.69%	45
2017 Q4	$1.89M	Buy	5,936 +346	+6%	+$111K	0.8%	39
2017 Q3	$1.75M	Buy	+5,590	New	+$1.66M	0.79%	42
2016 Q2	–	Sell	-110	Closed	-$30K	–	166
2016 Q1	$30K	Buy	+110	New	+$29.1K	0.01%	266

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ipswich Investment Management's BIIB Position: Q2 2020 in Review

Ipswich Investment Management sold out of Biogen (BIIB) in Q2 2020, closing a stake of 780 shares — an estimated $247K sold.

Ipswich Investment Management first reported a position in BIIB in Q1 2016 and held it in 11 quarters. The position peaked at $2.24M in Q3 2018. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

Ipswich Investment Management reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
Ipswich Investment Management sold 780 Biogen shares in Q2 2020, an estimated $247K.
Ipswich Investment Management first reported a position in Biogen in Q1 2016 and held it in 11 quarters.
Ipswich Investment Management's Biogen position peaked at $2.24M in Q3 2018.
1,059 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Ipswich Investment Management's 13F filing for Q2 2020, filed 9 Jul 2020.